RCAN1在恶性肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2017.06.015

摘要/Abstract

摘要： 钙调神经磷酸酶调节蛋白(Regulator of calcineurin 1,RCAN1)作为与钙调神经磷酸酶(Calcineurin,CaN)发生相互作用的内源性蛋白,在许多恶性肿瘤细胞中广泛表达,如小细胞肺癌、甲状腺癌、白血病、肝癌、恶性胶质细胞瘤、子宫内膜腺癌等。近年来研究显示,当RCAN1呈高表达状态时,可以通过多种途径来抑制肿瘤的增殖、分化、侵袭和转移,从而抑制肿瘤的进展。这些研究结果对患者的生存期和预后评估有着重要的指导作用,并对恶性肿瘤的治疗和干预奠定了一定的理论基础。

关键词: RCAN1, 恶性肿瘤, 进展

Abstract: Regulation of calcineurin 1(RCAN1),as an endogenous protein that interacts with calcineurin(CaN),widely expresses in many malignant tumor cells,such as small cell lung cancer,thyroid cancer,leukemia,liver cancer,malignant glioma,endometrial adenocarcinoma and so on.In recent years,many studies have been shown that when RCAN1 is highly expressed,it can inhibit tumor proliferation,differentiation,invasion and metastasis by a variety of ways,thereby inhibiting tumor progression.These findings play an important role in the survival and prognosis of patients,and provide a theoretical basis for the treatment and intervention of malignant tumors.

Key words: RCAN1, Tumors, Progression

中图分类号:

江莹, 刘宝刚审校. RCAN1在恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2017, 31(6): 559-563.

JIANG Ying, LIU Baogang. Research progress of RCAN1 in malignant tumor[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 559-563.

参考文献

1 Fuentes JJ,Pritchard MA,Planas AM,et al.A new human gene from the down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and,heart[J].Hum Mol Genet,1995,4(10):1935.
2 Patel A,Yamashita N,Ascao M,et al.RCAN1 links impaired neurotrophin trafficking to aberrant development of the sympathetic nervous system in down syndrome[J].Nat Commun,2015,6:10119.
3 Wong H,Levenga J,Cain P,et al.RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer′s disease[J].Acta Neuropathol,2015,130(6):829-843.
4 Torac E,Gaman L,Atanasiu V.The regulator of calcineurin(RCAN1)an important factor involved in atherosclerosis and cardiovascular diseases development[J].J Med Life,2014,7(4):481-487.
5 Peiris H,Raghupathi R,Jessup CF,et al.Increased expression of the glucose-responsive gene,RCAN1,causes hypoinsulinemia,β-cell dysfunction,and diabetes[J].Endocrinology,2012,153(11):5212-5221.
6 Ma N,Shen W,Pang H,et al.The effect of RCAN1 on the biological behaviors of small cell lung cancer[J].Tumour Biol,2017,39(6):1010428317700405.
7 马宁强,陈连宏,张贺龙,等.内源性CaN蛋白抑制剂RCAN1在肿瘤中的作用[J].现代肿瘤医学,2011,19(9):1866-1869.
8 Lu M,Zheng L,Han B,et al.Rest regulates dyrk1a transcription in a negative feedback loop[J].J Biol Chem,2011,286(12):10755-10763.
9 Xing L,Salas M,Zhang H,et al.Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1,(DSCR1)[J].Mammalian Genome,2013,24(1/2):30-43.
10 Kim SS,Jang SA,Su RS.CREB-mediated Bcl-2 expression contributes to RCAN1 protection from hydrogen peroxide-induced neuronal death[J].J Cell Biochem,2013,114(5):1115-1123.
11 Taromi S,Kayser G,Catusse J,et al.CXCR4 antagonists suppress small cell lung cancer progression[J].Oncotarget,2016,7(51):85185.
12 Pang H,Ma N,Jiao M,et al.The biological effects of dickkopf1 on small cell lung cancer cells and bone metastasis[J].Oncol Res,2017,25(1):35-42.
13 Miki T,Yano S,Hanibuchi M,et al.Bone metastasis model with multiorgan dissemination of human small-cell lung cancer(SBC-5)cells in natural killer cell-depleted SCID mice[J].Oncol Res,2000,12(5):209-217.
14 Stathatos N,Bourdeau I,Espinosa AV,et al.KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity[J].J Clin Endocrinol Metab,2005,90(9):5432-5440.
15 Wang C,Saji M,Justiniano SE,et al.RCAN1-4 is a thyroid cancer growth and metastasis suppressor[J].JCI Insight,2017,2(5):e90651.
16 Santos NRD,Ghezzo MN,Silva RCD,et al.NF-κB in T-cell acute lymphoblastic leukemia:oncogenic functions in leukemic and in microenvironmental cells[J].Cancers(Basel),2010,2(4):1838-1860.
17 Safa M,Tavasoli B,Manafi R,et al.Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells.[J].Tumour Biol,2015,36(5):3919-3930.
18 Savva CG,Totokotsopoulos S,Nicolaou KC,et al.Selective activation of TNFR1 and NF-κB inhibition by a novel biyouyanagin analogue promotes apoptosis in acute leukemia cells[J].BMC Cancer,2016,16(1):279.
19 Savl H,Akkoyunlu RU,Çine N,et al.Deregulated levels of the NF-κB1,NF-κB2,and rel genes in ukrainian patients with leukemia and lymphoma in the post-chernobyl period[J].Turk J Haematol,2016,33(1):8-14.
20 Bosman MC,Schuringa JJ,Vellenga E.Constitutive NF-κB activation in AML:Causes and treatment strategies.[J].Crit Rev Oncol Hematol,2016,98:35-44.
21 Kazuaki N,Yujiro I,Toshiyuki M.RCAN1 is an important mediator of glucocorticoid-induced apoptosis in human leukiemic cells[J].PLoS One,2012,7(11):e49926.
22 Jin H,Wang C,Jin G,et al.Regulator of calcineurin 1 Gene isoform 4,downregulated in hepatocellular carcinoma,prevents proliferation,migration,and invasive activity of cancer cells and growth of orthotopic tumors by inhibiting nuclear translocation of NFAT1[J].Gastroenterology,2017[Epub ahead of print].
23 Zucman-Rossi J,Villanueva A,Nault JC,et al.Genetic landscape and biomarkers of hepatocellular carcinoma[J].Gastroenterology,2015,149(5):1226-1239.
24 Kawahara T,Kashiwagi E,Ide H,et al.Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1[J].Oncotarget,2015,6(3):1582.
25 Kepes JJ,Rubinstein LJ.Malignant gliomas with heavily lipidized(foamy)tumor cells:a report of three cases with immunoperoxidase study.[J].Cancer,2015,47(10):2451-2459.
26 Vaccaro V,Fabi A,Vidiri A,et al.Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas.[J].Biomed Res Int,2014,2014(1):351252.
27 Tabatabaei P,Visse E,Bergström P,et al.Radiotherapy induces an immediate inflammatory reaction in malignant glioma:a clinical microdialysis study[J].J Neurooncol,2017,131(1):83-92.
28 Muroski ME,Morshed RA,Cheng Y,et al.Controlled payload release by magnetic field triggered neural stem cell destruction for malignant glioma treatment[J].PLoS One,2016,11(1):e0145129.
29 Mccowage GB,Friedman HS,Moghrabi A,et al.Activity of high‐dose cyclophosphamide in the treatment of childhood malignant gliomas[J].Med Pediatr Oncol,2015,30(2):75-80.
30 Yili W,Weihong S.Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis[J].FASEB J,2013,27(1):208.
31 Chen X,Hu Y,Wang S,et al.The regulator of calcineurin 1(RCAN1)inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth[J].Oncotarget,2017,8(7):12003-12012.
32 Genot JY,Krulik M,Poisson M,et al.Two cases of acute leukemia following treatment of malignant glioma[J].Cancer,2015,52(2):222-226.
33 Byron SA,Loch DC,Pollock PM.Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells[J].Int J Gynecol Cancer,2012,22(9):1517-1526.
34 Sales KJ,Grant V,Cook IH,et al.Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1[J].Am J Pathol,2010,176(1):435-445.

[1]	李吉, 陈杨, 张茂镕, 杨昭, 唐娴, 文洪梅. 中国常见消化系统恶性肿瘤伤残调整寿命年归因于人口老龄化的比例分析和趋势预测[J]. 实用肿瘤学杂志, 2025, 39(5): 372-380.
[2]	周素霞, 许志华, 郭淑玲, 范宁, 徐莉立. 2014—2021年青海省肿瘤登记地区恶性肿瘤发病与死亡流行趋势分析[J]. 实用肿瘤学杂志, 2025, 39(5): 381-387.
[3]	刘洋, 王颖, 马祥, 宋家宝, 刘大民, 陈丽莉. 2021年辽宁省营口市城市居民恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2025, 39(5): 400-404.
[4]	代晓泽, 马玉霞, 李雨婷, 齐笑晴, 祝天岑, 穆慧娟, 刘辉. 2014—2020年辽宁省阜新市城市居民恶性肿瘤发病与死亡流行趋势分析[J]. 实用肿瘤学杂志, 2025, 39(4): 278-283.
[5]	祝天岑, 礼彦侠, 任方晗, 代晓泽, 刘洋, 穆慧娟. 2021年辽宁省肿瘤登记地区恶性肿瘤流行情况分析[J]. 实用肿瘤学杂志, 2025, 39(4): 294-300.
[6]	李吉, 张茂镕, 杨昭, 文洪梅, 伍福仙, 李云涛. 2020年云南省昆明市肿瘤登记地区恶性肿瘤发病和死亡特征及2016—2020年趋势分析[J]. 实用肿瘤学杂志, 2025, 39(3): 169-176.
[7]	文小焱, 陈俐. 2010年和2020年四川省30岁及以上人群恶性肿瘤疾病负担比较分析[J]. 实用肿瘤学杂志, 2025, 39(1): 1-6.
[8]	陈茂森, 陈杨, 石青萍, 邵英, 唐娴, 任思颖, 文洪梅. 2020年云南省恶性肿瘤发病和死亡分析[J]. 实用肿瘤学杂志, 2024, 38(5): 283-288.
[9]	苏锋, 梁磊, 邓英, 张同蕾, 王艳平. 2016—2020年陕西省安康市恶性肿瘤流行特征和变化趋势分析[J]. 实用肿瘤学杂志, 2024, 38(5): 300-305.
[10]	何佳颖, 朱津丽, 贾凯旋, 杨佩颖. IFN-γ在肿瘤免疫检查点抑制剂治疗中的研究进展[J]. 实用肿瘤学杂志, 2024, 38(5): 330-335.
[11]	刘丽莉, 张雪云, 张雷. 2020—2022年第一师阿拉尔市恶性肿瘤发病分析[J]. 实用肿瘤学杂志, 2024, 38(4): 246-253.
[12]	钟女娟, 马晶昱, 许志达. 2019年福建省福清市恶性肿瘤发病与死亡情况及2015—2019年趋势分析[J]. 实用肿瘤学杂志, 2024, 38(1): 1-6.
[13]	鲁亚杰, 王丽红. 蒽环类药物相关心脏毒性早期生物标志物研究进展[J]. 实用肿瘤学杂志, 2023, 37(6): 496-501.
[14]	程锦, 王玮. 维甲酸诱导蛋白在消化系统恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2023, 37(6): 502-506.
[15]	赵世博, 陈永峰, 黎惠怡, 符爱珍. Agrin参与恶性肿瘤发生发展的研究现状[J]. 实用肿瘤学杂志, 2023, 37(6): 507-512.